Summary:

TERN has Big-Mover readout in Q3, 2023 in NASH, and has an active, early stage pipeline in NASH, weight loss, and oncology. Our biopharma hedge fund data gave us the idea to look closer into TERN.

Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...

$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...

$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...

Updated 6/27/22 Summary The International Liver Congress (ILC) 2022 is taking place from June 22 - 26 in-person at ExCeL in London and...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...